Kennerman Associates reports 42.4% stake in Radnostix
Radnostix, Inc. disclosure: Kennerman Associates, Inc. reports beneficial ownership of 237,489,559 shares of common stock, representing 42.4% of the class based on March 26, 2026.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Radnostix, Inc. disclosure: Kennerman Associates, Inc. reports beneficial ownership of 237,489,559 shares of common stock, representing 42.4% of the class based on March 26, 2026. The holding includes 5,000,000 vested options exercisable within 60 days and 26,300,000 shares issuable on conversion of Series C Preferred Stock.
Christopher Grosso is identified as a principal of Kennerman Associates and is reported as beneficially owning 65,645,540 shares (12.1%), which includes options and Series C conversion rights; Grosso disclaims beneficial ownership of a portion of the securities reported.
Key Figures
Kennerman shares beneficially owned:237,489,559 sharesKennerman percent of class:42.4%Vested options included:5,000,000 shares+3 more
6 metrics
Kennerman shares beneficially owned237,489,559 sharesownership reported in Schedule 13G
Kennerman percent of class42.4%based on 528,209,538 shares outstanding as of March 26, 2026
Vested options included5,000,000 sharesoptions exercisable within 60 days
Series C conversion (Kennerman)26,300,000 sharesissuable upon conversion of Series C Preferred Stock
Christopher Grosso beneficial ownership65,645,540 sharesreported aggregate beneficial ownership
Grosso percent of class12.1%based on 523,706,140 shares outstanding as of March 26, 2026
Key Terms
beneficial ownership, Series C Convertible Redeemable Preferred Stock, vested stock options exercisable within 60 days
3 terms
beneficial ownershipregulatory
"Amount beneficially owned: As of the date of this filing"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Series C Convertible Redeemable Preferred Stockfinancial
"26,300,000 shares of common stock issuable upon conversion of the issuer's Series C Convertible Redeemed Preferred Stock"
vested stock options exercisable within 60 daysfinancial
"5,000,000 shares of common stock subject to vested stock options exercisable within 60 days"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Kennerman Associates report in INIS?
Kennerman Associates reports beneficial ownership of 237,489,559 shares, equal to 42.4% of the class based on March 26, 2026. This total includes vested options exercisable within 60 days and shares issuable upon conversion of Series C Preferred Stock.
How much of INIS does Christopher Grosso beneficially own?
Christopher Grosso is reported as beneficially owning 65,645,540 shares, or 12.1% of the class based on the filing. His reported total includes vested options and shares issuable upon conversion of Series C Preferred Stock, and he disclaims ownership of certain securities.
Which convertible or option instruments are included in the reported INIS holdings?
The reported holdings include 5,000,000 vested options exercisable within 60 days and 26,300,000 shares issuable upon conversion of the issuer's Series C Convertible Redeemable Preferred Stock, as stated in the filing's comment section.
What outstanding share bases does the filing cite for INIS percentages?
The filing cites two outstanding share figures: 528,209,538 shares as of March 26, 2026 and 523,706,140 shares as of March 26, 2026 in related statements; each outstanding count is used to calculate the reported percentage ownership in the cover comments.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
RADNOSTIX INC
(Name of Issuer)
Common stock
(Title of Class of Securities)
45972C102
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
45972C102
1
Names of Reporting Persons
Kennerman Associates, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NEW YORK
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
237,489,559.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
237,489,559.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
42.4 %
12
Type of Reporting Person (See Instructions)
IA
Comment for Type of Reporting Person: (1) 5,000,000 shares of common stock subject to vested stock options exercisable within 60 days of the date hereof and (ii) 26,300,000 shares of common stock issuable upon conversion of the issuer's Series C Convertible Redeemed Preferred Stock
(2) Based on 528,209,538 shares of common stock outstanding as of March 26, 2026 as reported in the issuer's Annual Report on Form 10-K for the year ended December 31, 2025.
SCHEDULE 13G
CUSIP Number(s):
45972C102
1
Names of Reporting Persons
GROSSO CHRISTOPHER G
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
60,542,959.00
6
Shared Voting Power
5,102,581.00
7
Sole Dispositive Power
5,000,000.00
8
Shared Dispositive Power
55,542,959.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
65,645,540.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
12.1 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) Includes 5,000,000 shares of common stock subject to vested stock options exercisable within 60 days of the date hereof and (ii) 5,040,000 shares of common stock issuable upon conversion of Series C Preferred Stock.
(2) Includes (i) 2,189,697 shares of common stock and (ii) 2,000,000 shares of common stock issuable upon conversion of Series C Preferred Stock, in each case held by the reporting person's father's, for which the reporting person shares investment control.
(3) Includes (i) 562,884 shares of common stock and (ii) 350,000 shares of common stock issuable upon conversion of Series C Preferred Stock, in each case held by the reporting person's son, for which the reporting person shares investment control.
(4) Based on 523,706,140 shares of common stock outstanding as of March 26, 2026 as reported in the issuer's Annual Report of Form 10-K for the year ended December 31, 2025.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
RADNOSTIX INC
(b)
Address of issuer's principal executive offices:
4137 COMMERCE CIRCLE, IDAHO FALLS, IDAHO, 83401.
Item 2.
(a)
Name of person filing:
Kennerman Associates, Inc. d/b/a Kershner Grosso & Co.
Christopher Grosso
(b)
Address or principal business office or, if none, residence:
480 Broadway, Suite 310
Saratoga Springs, NY 12866
(c)
Citizenship:
United States
(d)
Title of class of securities:
Common stock
(e)
CUSIP Number(s):
45972C102
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the date of this filing, each of Kennerman Associates, Inc. d/b/a Kershner Grosso & Co. and Christopher Gross beneficially own the aggregate number and percentage of common stock of Radnostix, Inc.
As of the date of this filing, Kennerman Associates, Inc. d/b/a Kershner Grosso & Co. had beneficial ownership 237,489,559 shares of common stock of Radnostix, Inc. ("Shares"), including (i) vested options to purchase 5,000,000 Shares that were exercisable within 60 days of the date hereof ("Options"), and (iii) 26,300,000 shares of common stock issuable upon conversion of the issuer's Series C Convertible Redeemable Preferred Stock ("Series C Preferred Stock"). Christoper Grosso is a principal of Kennerman Assocates, Inc., and may be deemed to have beneficial ownership of the Shares and Options beneficially owned by Kennerman Associates, Inc.
The filing of this report shall not be construed as an admission of Christoper Grosso is, for purposes of Section 13(d) or 13(g) of Act or for any other purposes, the beneficial owner of the Shares or Options. Christopher Grosso disclaims beneficial ownership 170,999,219 Shares, Options, Warrants and Series C Preferred Stock covered by this Schedule 13G/A.
(b)
Percent of class:
See Item 11 of each cover page above.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Sole power to vote or to direct the vote: See Item 5 of cover page above.
(ii) Shared power to vote or to direct the vote:
Shared power to vote or to direct the vote: see Item 6 of cover page above.
(iii) Sole power to dispose or to direct the disposition of:
Sole power to dispose or direct the disposition of: see Item 7 of cover page above.
(iv) Shared power to dispose or to direct the disposition of:
Shared power to dispose of or to direct the disposition of: see Item 8 cover page above.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 4(a) above.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
